cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.hhtfzm
title: Occurrence Download

description: A dataset listing the 1127 species recorded in GBIF matching the query:
{
 "and" : [
 "Country is Somalia",
 "OccurrenceStatus is Present",
 "TaxonKey is Arthropoda"
 ]
}

 The dataset's 1127 records were derived from 125 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0076126-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.35jthh
title: Occurrence Download

description: A dataset containing 80990 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Plantae",
 "Country is Iran (Islamic Republic of)"
 ]
}

 The dataset includes 80990 records from 117 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0000709-150311145101897/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.bkuy9q
title: Occurrence Download

description: A dataset containing 243523 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Setophaga townsendi (J.K.Townsend, 1837)"
 ]
}

 The dataset includes 243523 records from 114 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007949-180508205500799/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.2n9bez
title: Occurrence Download

description: A dataset containing 675 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Ficus neriifolia Sm."
 ]
}

 The dataset includes 675 records from 36 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0243826-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ghvnsb
title: Occurrence Download

description: A dataset containing 10 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Molossops greenhalli (Goodwin, 1958)",
 "Geometry POLYGON((-92.636718 14.859850,-91.757812 16.045813,-90.263671 16.214674,-91.142578 17.476432,-88.945312 17.895114,-87.890625 18.812717,-86.572265 21.453068,-88.066406 21.371244,-89.648437 21.207458,-90.439453 20.715015,-91.494140 18.812717,-93.251953 18.312810,-95.185546 18.479609,-96.679687 20.303417,-97.382812 21.616579,-97.734375 22.674847,-97.558593 24.766784,-97.119140 25.958044,-98.876953 26.509904,-99.580078 27.527758,-100.546875 28.767659,-101.425781 29.840643,-102.304687 29.840643,-103.095703 29.075375,-104.589843 29.764377,-105.117187 30.751277,-106.435546 31.728167,-108.28125 31.728167,-108.369140 31.503629,-111.093749 31.428663,-115.136718 32.768800,-117.070312 32.472695,-115.488281 29.458731,-113.90625 28.381735,-115.136718 27.527758,-111.796875 25.720735,-111.884765 24.686952,-109.863281 22.755920,-109.511718 23.402764,-110.917968 25.482951,-112.236328 27.449790,-113.466796 29.152161,-114.521484 29.840643,-114.697265 32.026706,-112.587890 30.069093,-109.335937 26.037041,-105.029296 21.616579,-105.820312 20.468189,-102.304687 17.644022,-98.789062 16.467694,-96.152343 15.538375,-94.21875 16.214674,-92.636718 14.859850))",
 {
 "or" : [
 "HasGeospatialIssue is true",
 "HasGeospatialIssue is false"
 ]
 }
 ]
}

 The dataset includes 10 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0000709-150422101436696/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.auq3yz
title: Occurrence Download

description: A dataset containing 1303 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Amygdalus L."
 ]
}

 The dataset includes 1303 records from 43 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0052819-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.21228874
title: Additional file 2 of Identification of a hippocampal lncRNA-regulating network in a natural aging rat model

description: Additional file 2: The dramatically differentially expressed lncRNAs in the aging and 9-month control groups.
DOI: 10.6084/m9.figshare.12315989
title: Additional file 9 of Role of phasiRNAs from two distinct phasing frames of GhMYB2 loci in cis- gene regulation in the cotton genome

description: Additional file 9: Table S3. The miR173 and miR390 predicted target in cotton genome
DOI: 10.6084/m9.figshare.12315989.v1
title: Additional file 9 of Role of phasiRNAs from two distinct phasing frames of GhMYB2 loci in cis- gene regulation in the cotton genome

description: Additional file 9: Table S3. The miR173 and miR390 predicted target in cotton genome
DOI: 10.6084/m9.figshare.12315980
title: Additional file 7 of Role of phasiRNAs from two distinct phasing frames of GhMYB2 loci in cis- gene regulation in the cotton genome

description: Additional file 7: Table S1. phasiRNA read number in small RNA libraries from two phasing frames on GhMYB2
DOI: 10.6084/m9.figshare.12315986.v1
title: Additional file 8 of Role of phasiRNAs from two distinct phasing frames of GhMYB2 loci in cis- gene regulation in the cotton genome

description: Additional file 8: Table S2. The mapping statistics for the small RNA libraries and degradome libraries used in this study
DOI: 10.6084/m9.figshare.13888885
title: Additional file 5 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 5: Table S5. Statistical test results related to Table S4.
DOI: 10.6084/m9.figshare.13888864
title: Additional file 1 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 1: Table S1. Statistical test results related to Table 2.
DOI: 10.6084/m9.figshare.12299588.v1
title: Additional file 12 of Integrated small RNA and mRNA expression profiles reveal miRNAs and their target genes in response to Aspergillus flavus growth in peanut seeds

description: Additional file 12: Table S9. Summary of RNA-seq reads from the individual libraries.
DOI: 10.6084/m9.figshare.13888885.v1
title: Additional file 5 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 5: Table S5. Statistical test results related to Table S4.
DOI: 10.6084/m9.figshare.13888870.v1
title: Additional file 2 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 2: Table S2. Demographic and clinical features between survivors and nonsurvivors of 81 critically ill patients with COVID-19.
DOI: 10.6084/m9.figshare.14920935.v1
title: Additional file 3 of Genome-wide identification, expression analysis, and functional study of the GRAS transcription factor family and its response to abiotic stress in sorghum [Sorghum bicolor (L.) Moench]

description: Additional file 3: Table S3. Analysis and distribution of the conserved motifs of GRAS proteins.
DOI: 10.6084/m9.figshare.13888888
title: Additional file 6 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 6: Table S6. Median, interquartile and statistical test results across different hospitalization days between survivors and nonsurvivors on different days before outcome related to Fig. 3.
DOI: 10.6084/m9.figshare.13888888.v1
title: Additional file 6 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 6: Table S6. Median, interquartile and statistical test results across different hospitalization days between survivors and nonsurvivors on different days before outcome related to Fig. 3.
DOI: 10.6084/m9.figshare.13888891.v1
title: Additional file 7 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 7: Table S7. laboratory indices among survivors and nonsurvivors of 81 critically ill patients with COVID-19.
DOI: 10.6084/m9.figshare.13888876
title: Additional file 3 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 3: Table S3. Median, interquartile and statistical test results across different hospitalization days among mild, severe, critical patients related to Fig. 2.
DOI: 10.6084/m9.figshare.13888876.v1
title: Additional file 3 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 3: Table S3. Median, interquartile and statistical test results across different hospitalization days among mild, severe, critical patients related to Fig. 2.
DOI: 10.6084/m9.figshare.13888870
title: Additional file 2 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 2: Table S2. Demographic and clinical features between survivors and nonsurvivors of 81 critically ill patients with COVID-19.
DOI: 10.6084/m9.figshare.13888882
title: Additional file 4 of Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients

description: Additional file 4: Table S4. Laboratory indices of maximum values in individual patients with mild, severe, critical syndromes during the hospital stay.
DOI: 10.6084/m9.figshare.14937725
title: Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis

description: Glioblastoma multiforme (GBM) is the most fatal malignancy, and despite extensive treatment, tumors inevitably recur. This study aimed to identify recurrence-associated molecules in GBM. The gene expression profile GSE139533, containing 70 primary and 47 recurrent GBM tissues and their corresponding clinical traits, was downloaded from the Gene Expression Omnibus (GEO) database and used for weighted gene co-expression network analysis (WGCNA) and differentially expressed gene (DEG) analysis. After identifying the hub genes which differentially expressed in recurrent GBM tissues and in the gene modules correlated with recurrence, data from the Chinese Glioma Genome Atlas (CCGA) and The Cancer Genome Atlas (TCGA) databases were analyzed with GSE43378 to determine the relationship between hub genes and patient prognosis. The diagnostic value of the identified hub genes was verified using 52 GBM tissues. Three gene modules were correlated with recurrence and 2623 genes were clustered in these clinically significant modules. Among these, 13 genes – <i>EHF, TRPM1, FXYD4, CDH15, LHX5, TP73, FBN3, TLX1, C1QL4, COL2A, SEC61G, NEUROD4</i> and <i>GPR139</i> – were differentially expressed in recurrent GBM samples; low <i>LHX5</i> and <i>TLX1</i> expression predicted poor outcomes. <i>LHX5</i> and <i>TLX1</i> expression showed weak positive relationships with Karnofsky performance scale scores. Additionally, <i>LHX5</i> and <i>TLX1</i> expression was found to be decreased in our recurrent GBM samples compared with that in primary samples; these genes exhibited high diagnostic value in distinguishing recurrent samples from primary samples. Our findings indicate that <i>LHX5</i> and <i>TLX1</i> might be involved in GBM recurrence and act as potential biomarkers for this condition.
DOI: 10.6084/m9.figshare.14937725.v1
title: Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis

description: Glioblastoma multiforme (GBM) is the most fatal malignancy, and despite extensive treatment, tumors inevitably recur. This study aimed to identify recurrence-associated molecules in GBM. The gene expression profile GSE139533, containing 70 primary and 47 recurrent GBM tissues and their corresponding clinical traits, was downloaded from the Gene Expression Omnibus (GEO) database and used for weighted gene co-expression network analysis (WGCNA) and differentially expressed gene (DEG) analysis. After identifying the hub genes which differentially expressed in recurrent GBM tissues and in the gene modules correlated with recurrence, data from the Chinese Glioma Genome Atlas (CCGA) and The Cancer Genome Atlas (TCGA) databases were analyzed with GSE43378 to determine the relationship between hub genes and patient prognosis. The diagnostic value of the identified hub genes was verified using 52 GBM tissues. Three gene modules were correlated with recurrence and 2623 genes were clustered in these clinically significant modules. Among these, 13 genes – <i>EHF, TRPM1, FXYD4, CDH15, LHX5, TP73, FBN3, TLX1, C1QL4, COL2A, SEC61G, NEUROD4</i> and <i>GPR139</i> – were differentially expressed in recurrent GBM samples; low <i>LHX5</i> and <i>TLX1</i> expression predicted poor outcomes. <i>LHX5</i> and <i>TLX1</i> expression showed weak positive relationships with Karnofsky performance scale scores. Additionally, <i>LHX5</i> and <i>TLX1</i> expression was found to be decreased in our recurrent GBM samples compared with that in primary samples; these genes exhibited high diagnostic value in distinguishing recurrent samples from primary samples. Our findings indicate that <i>LHX5</i> and <i>TLX1</i> might be involved in GBM recurrence and act as potential biomarkers for this condition.
DOI: 10.6084/m9.figshare.13181246
title: Acute ischemic stroke management: concepts and controversies.A narrative review

description: Amongst the 25.7 million survivors and 6.5 million deaths from stroke between 1990 and 2013, ischemic strokes accounted for approximately 70% and 50% of the cases, respectively. With patients still suffering from complications and stroke recurrence, more questions have been raised as to how we can better improve patient management. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and Newcastle-Ottawa Scale (NOS) were adopted to ensure a comprehensive inclusion of quality literature from various sources. PubMed and Embase were searched for evidence on thrombolysis, mechanical thrombectomy, artificial intelligence (AI), antiplatelet therapy, anticoagulation and hypertension management. The directions of future research in these areas are dependent on the current level of validation. Endovascular therapy and applications of AI are relatively new compared to the other areas discussed in this review. As such, future studies need to focus on validating their efficacy. As for thrombolysis, antiplatelet and anticoagulation therapy, their efficacy has been well-established and future research efforts should be directed toward adjusting its use according to patient-specific factors, starting with factors with the most clinical relevance and prevalence.
DOI: 10.6084/m9.figshare.13181246.v1
title: Acute ischemic stroke management: concepts and controversies.A narrative review

description: Amongst the 25.7 million survivors and 6.5 million deaths from stroke between 1990 and 2013, ischemic strokes accounted for approximately 70% and 50% of the cases, respectively. With patients still suffering from complications and stroke recurrence, more questions have been raised as to how we can better improve patient management. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and Newcastle-Ottawa Scale (NOS) were adopted to ensure a comprehensive inclusion of quality literature from various sources. PubMed and Embase were searched for evidence on thrombolysis, mechanical thrombectomy, artificial intelligence (AI), antiplatelet therapy, anticoagulation and hypertension management. The directions of future research in these areas are dependent on the current level of validation. Endovascular therapy and applications of AI are relatively new compared to the other areas discussed in this review. As such, future studies need to focus on validating their efficacy. As for thrombolysis, antiplatelet and anticoagulation therapy, their efficacy has been well-established and future research efforts should be directed toward adjusting its use according to patient-specific factors, starting with factors with the most clinical relevance and prevalence.
DOI: 10.6084/m9.figshare.23780781
title: Data from "Surveys that prioritize site number over time per site will result in better gastropod status assessments: a case study on the rediscovery of Big Black Rocksnail"

description: Freshwater gastropods are among the most imperiled organisms on earth. Yet, they are among the most understudied freshwater taxon. Many freshwater gastropod species have gone extinct in the last 100 years, but recent rediscoveries indicate that inadequate survey work has resulted in some species being prematurely declared extinct. Such premature declaration of extinction can remove legal protections for species, which could then actually cause extinction. Thus, research and policy recommendations are needed so surveys provide the best information possible for conservation. Here, we examined the case of <i>Lithasia hubrichti</i>, a freshwater gastropod endemic to the Big Black River in Mississippi that was last seen in 1965. In 2022, a freshwater mollusk survey resulted in finding <i>L. hubrichti</i> alive. An additional survey effort in 2023 that prioritized sampling as many sites as possible in a single day clarified the current range of <i>L. hubrichti</i>.<i> </i>Genomic analyses indicated that the species has persisted with a large population size for thousands of years, rather than ever falling below a survey detection limit. When considering the case of <i>L. hubrichti </i>and other recent freshwater gastropod rediscoveries, we conclude that freshwater gastropod surveys should emphasize sampling as many sites as possible when targeting rare species, rather than expending high sampling effort at a small number of sites. We also advocate for policies that encourage partnerships with landowners, which was required to rediscover <i>L. hubrichti</i>.
DOI: 10.6084/m9.figshare.23780781.v1
title: Data from "Surveys that prioritize site number over time per site will result in better gastropod status assessments: a case study on the rediscovery of Big Black Rocksnail"

description: Freshwater gastropods are among the most imperiled organisms on earth. Yet, they are among the most understudied freshwater taxon. Many freshwater gastropod species have gone extinct in the last 100 years, but recent rediscoveries indicate that inadequate survey work has resulted in some species being prematurely declared extinct. Such premature declaration of extinction can remove legal protections for species, which could then actually cause extinction. Thus, research and policy recommendations are needed so surveys provide the best information possible for conservation. Here, we examined the case of <i>Lithasia hubrichti</i>, a freshwater gastropod endemic to the Big Black River in Mississippi that was last seen in 1965. In 2022, a freshwater mollusk survey resulted in finding <i>L. hubrichti</i> alive. An additional survey effort in 2023 that prioritized sampling as many sites as possible in a single day clarified the current range of <i>L. hubrichti</i>.<i> </i>Genomic analyses indicated that the species has persisted with a large population size for thousands of years, rather than ever falling below a survey detection limit. When considering the case of <i>L. hubrichti </i>and other recent freshwater gastropod rediscoveries, we conclude that freshwater gastropod surveys should emphasize sampling as many sites as possible when targeting rare species, rather than expending high sampling effort at a small number of sites. We also advocate for policies that encourage partnerships with landowners, which was required to rediscover <i>L. hubrichti</i>.
DOI: 10.6084/m9.figshare.7597649.v1
title: A snare combined with endoclips to assist in endoscopic submucosal dissection for intraepithelial neoplasia in the entire colon and rectum

description: <b>Objective:</b> The use of mucosal traction to assist in colonic and rectal endoscopic submucosal dissection (ESD), especially for deep colonic ESD, is challenging. We developed a method of inverse insertion of a snare into the endoscopic working channel to deliver it into the colon together with the endoscope. With this method, two types of mucosal traction, per-anal external traction (PET) and per-anal internal traction (PIT), could be achieved using a snare with endoclips to assist in ESD (ESD-SE). Here, we aimed to examine its safety and feasibility. <b>Methods:</b> From January 2017 to September 2018, 50 colonic and rectal intraepithelial neoplasias in 50 patients were treated with ESD-SE. Data on lesion location and size, operation time, en bloc resection and R0 resection rates, and operative complications were collected. <b>Results:</b> Among 50 lesions, 15 lesions were located in the deep colon/proximal colon, and 35 lesions were in the distal colon. The median (interquartile range) size of lesions, submucosal dissection time, and total operation time were 4.5 (3.0–5.0) cm, 32 (18–81) min, and 50 (33–108) min, respectively. All lesions were completely resected, with R0 resection rates of 100%. No intraoperative and postoperative complications occurred. Postoperative pathology revealed 40 and 10 cases of high-grade and low-grade intraepithelial neoplasia, respectively. <b>Conclusions:</b> The approach using insertion of a selective snare into the colon together with the endoscope, especially into the deep colon, was safe and simple. Use of the snare combined with endoclips could effectively assist in total colonic ESD. Further research is warranted.
DOI: 10.6084/m9.figshare.13888923
title: Additional file 6 of Genome-wide identification of chitinase genes in Thalassiosira pseudonana and analysis of their expression under abiotic stresses

description: Additional file 6: Table S6. Top 3D models predicted of of the TpChi proteins.
DOI: 10.6084/m9.figshare.13888935.v1
title: Additional file 9 of Genome-wide identification of chitinase genes in Thalassiosira pseudonana and analysis of their expression under abiotic stresses

description: Additional file 9: Table S9. Primers used in qRT-PCR studies.
DOI: 10.6084/m9.figshare.13888920
title: Additional file 5 of Genome-wide identification of chitinase genes in Thalassiosira pseudonana and analysis of their expression under abiotic stresses

description: Additional file 5: Table S5. The proportion of secondary structure of the TpChi proteins.
DOI: 10.6084/m9.figshare.13888932.v1
title: Additional file 8 of Genome-wide identification of chitinase genes in Thalassiosira pseudonana and analysis of their expression under abiotic stresses

description: Additional file 8: Table S8. All transcripts annotated as chitinase in T. pseudonana genome from JGI database.
DOI: 10.6084/m9.figshare.13888926.v1
title: Additional file 7 of Genome-wide identification of chitinase genes in Thalassiosira pseudonana and analysis of their expression under abiotic stresses

description: Additional file 7: Table S7. Keywords used for searching T. pseudonana chitinase genes on JGI.
DOI: 10.6084/m9.figshare.13888902
title: Additional file 1 of Genome-wide identification of chitinase genes in Thalassiosira pseudonana and analysis of their expression under abiotic stresses

description: Additional file 1: Table S1. Analysis and prediction of signal peptides, Transmembrane helices (TMHs) and Subcellular localizations of the TpChi proteins.